Results 1 to 6 of 6
  1. #1
    somenewguy is offline New Member
    Join Date
    Jan 2005
    Posts
    40

    can proviron be sub'd for nolvadex during pct?

    it seems a friend can only get proviron right now?

  2. #2
    Josey Wales's Avatar
    Josey Wales is offline Associate Member
    Join Date
    Dec 2004
    Posts
    214
    No. On the one hand it will not do what Nolva does, which is ensure that estrogen doesn't affect the breast tissue. And the other hand, it will not allow you to recover your hormone levels.

  3. #3
    Join Date
    Apr 2002
    Posts
    1,733
    Read the profile on Proviron , and you tell us if it can.....

  4. #4
    abstrack's Avatar
    abstrack is offline AR-Hall of Famer
    Join Date
    May 2002
    Posts
    7,358
    Quote Originally Posted by hooker
    Read the profile on Proviron, and you tell us if it can.....
    WHAT? Read? F that




    abstrack@protonmail.com

  5. #5
    Join Date
    Apr 2002
    Posts
    1,733
    Horm Metab Res. 1984 Sep;16(9):492-7.


    Effect of non aromatizable androgens on LHRH and TRH responses in primary testicular failure.

    Spitz IM, Margalioth EJ, Yeger Y, Livshin Y, Zylber-Haran E, Shilo S.

    We have assessed the gonadotropin, TSH and PRL responses to the non aromatizable androgens, mesterolone and fluoxymestrone, in 27 patients with primary testicular failure. All patients were given a bolus of LHRH (100 micrograms) and TRH (200 micrograms) at zero time. Nine subjects received a further bolus of TRH at 30 mins. The latter were then given mesterolone 150 mg daily for 6 weeks. The remaining subjects received fluoxymesterone 5 mg daily for 4 weeks and 10 mg daily for 2 weeks. On the last day of the androgen administration, the subjects were re-challenged with LHRH and TRH according to the identical protocol. When compared to controls, the patients had normal circulating levels of testosterone , estradiol, PRL and thyroid hormones. However, basal LH, FSH and TSH levels, as well as gonadotropin responses to LHRH and TSH and PRL responses to TRH, were increased. Mesterolone administration produced no changes in steroids, thyroid hormones, gonadotropins nor PRL. There was, however, a reduction in the integrated and incremental TSH secretion after TRH. Fluoxymesterone administration was accompanied by a reduction in thyroid binding globulin (with associated decreases in T3 and increases in T3 resin uptake). The free T4 index was unaltered, which implies that thyroid function was unchanged. In addition, during fluoxymesterone administration, there was a reduction in testosterone , gonadotropins and LH response to LHRH. Basal TSH did not vary, but there was a reduction in the peak and integrated TSH response to TRH. PRL levels were unaltered during fluoxymesterone treatment.(ABSTRACT TRUNCATED AT 250 WORDS)


    Int J Gynaecol Obstet. 1988 Feb;26(1):121-8.


    The effect of mesterolone on sperm count, on serum follicle stimulating hormone, luteinizing hormone, plasma testosterone and outcome in idiopathic oligospermic men.

    Varma TR, Patel RH.

    Department of Obstetrics & Gynaecology, St. George's Hospital Medical School London, U.K.

    Two hundred fifty subfertile men with idiopathic oligospermia (count less than 20 million/ml) were treated with mesterolone (100-150 mg/day) for 12 months. Seminal analysis were assayed 3 times and serum follicle stimulating hormone (FSH) luteinizing hormone (LH) and plasma testosterone were assayed once before treatment and repeated at 3, 6, 9 and 12 months after the initiation of treatment. One hundred ten patients (44%) had normal serum FSH, LH and plasma testosterone, 85 patients (34%) had low serum FSH, LH and low plasma testosterone. One hundred seventy-five patients (70%) had moderate oligospermia (count 5 to less than 20 million/ml) and 75 patients (30%) had severe oligospermia (count less than 5 million/ml). Seventy-five moderately oligospermic patients showed significant improvement in the sperm density, total sperm count and motility following mesterolone therapy whereas only 12% showed improvement in the severe oligospermic group. Mesterolone had no depressing effect on low or normal serum FSH and LH levels but had depressing effect on 25% if the levels were elevated. There was no significant adverse effect on testosterone levels or on liver function. One hundred fifteen (46%) pregnancies resulted following the treatment, 9 of 115 (7.8%) aborted and 2 (1.7%) had ectopic pregnancy. Mesterolone was found to be more useful in patients with a sperm count ranging between 5 and 20 million/ml. Those with severe oligospermia (count less than 5 million) do not seem to benefit from this therapy.

  6. #6
    abstrack's Avatar
    abstrack is offline AR-Hall of Famer
    Join Date
    May 2002
    Posts
    7,358
    Now thats what I tell my customers! I am working for you! I like to make things happen for you!
    abstrack@protonmail.com

Thread Information

Users Browsing this Thread

There are currently 1 users browsing this thread. (0 members and 1 guests)

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •